Postthrombotic Syndrome
22
3
3
11
Key Insights
Highlights
Success Rate
85% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 42/100
9.1%
2 terminated out of 22 trials
84.6%
-1.9% vs benchmark
32%
7 trials in Phase 3/4
18%
2 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (22)
Acute or Subacute Iliofemoral Vein Thrombosis: Aspiration for Flow Restoration Versus Standard Anticoagulation
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
DVT Burden and the Risk of Post-thrombotic Syndrome
Design and Rationale of the COLT Study
Novel PET/CT and Treatment Strategies to Reduce PTS Following DVT
Ongoing Registry of Treatment of Venous Thromboembolism
The MUFFIN-PTS Trial
Bern Venous Stent Registry
Flow Augmentation Study in Postthrombotic Patients
Mechanisms of Deep Vein Thrombosis (DVT) and Vein Wall Fibrosis
Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic® Endovascular System
Rivaroxaban With Diosmin in Long-term Treatment of Deep Vein Thrombosis
Treatment of the Postthrombotic Syndrome With the Oblique Stent - TOPOS Study
Elastic Compression Stockings for Prevention of Post-thrombotic Syndrome
Prevalence of Post-Thrombotic Syndrome in Deep-Vein Thrombosis (DVT) Patients Treated With Dabigatran
Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial
The 36-month Extension to Follow up Sub Study
The Ideal Deep Venous Thrombosis (DVT) Study
Prospective Evaluation of the QoL of Patients With PTS Who Receive Compression Therapy and Sulodexide
Treadmill Pilot Study (Invasive Pressure Measurements in PTS)